NIH draft would extend data and safety monitoring beyond clinical trials, pushing institutions to map new workflows before Jan. 6
NIH’s November 2, 2026 draft Data and Safety Monitoring policy would broaden scope to all NIH-supported clinical research, require ICO-approved risk-based monitoring plans, and tie compliance to award terms. For research administrators, the immediate question is not implementation but where current intake, approval and amendment workflows would break if the draft is finalized.